Ultragenyx Pharmaceutical (RARE) Return on Sales Growth (5y) (2021 - 2026)
Ultragenyx Pharmaceutical (RARE) Return on Sales Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.71 Bn | 2.30 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -2.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | 2.00 |
| Dec 31, 2024 | -9.00 |
| Sep 30, 2024 | 3.00 |
| Jun 30, 2024 | 3.00 |
| Mar 31, 2024 | 4.00 |
| Dec 31, 2023 | 4.00 |
| Sep 30, 2023 | 6.00 |
| Jun 30, 2023 | 3.00 |
| Mar 31, 2023 | -4.00 |
| Dec 31, 2022 | 5.00 |
| Sep 30, 2022 | 397.00 |
| Dec 31, 2021 | 14,254.00 |
| Sep 30, 2021 | 584.00 |
| Jun 30, 2021 | 3,347.00 |